Annotation Detail
Information
- Associated Genes
- KRAS
- Associated Variants
-
KRAS p.Gly13Val (p.G13V)
(
ENST00000256078.10,
ENST00000311936.8,
ENST00000556131.2,
ENST00000557334.6,
ENST00000685328.1,
ENST00000686969.1,
ENST00000688940.1,
ENST00000692768.1,
ENST00000693229.1 )
KRAS p.Gly13Ala (p.G13A) ( ENST00000557334.6, ENST00000256078.10, ENST00000688940.1, ENST00000311936.8, ENST00000686969.1, ENST00000685328.1, ENST00000693229.1, ENST00000692768.1, ENST00000556131.2 )
KRAS p.Gly13Asp (p.G13D) ( ENST00000256078.10, ENST00000311936.8, ENST00000556131.2, ENST00000685328.1, ENST00000557334.6, ENST00000686969.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 )
KRAS p.Gly13Val (p.G13V) ( ENST00000256078.10, ENST00000311936.8, ENST00000556131.2, ENST00000686969.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1, ENST00000557334.6, ENST00000685328.1 )
KRAS p.Gly13Ala (p.G13A) ( ENST00000256078.10, ENST00000311936.8, ENST00000556131.2, ENST00000557334.6, ENST00000685328.1, ENST00000686969.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 )
KRAS p.Gly13Asp (p.G13D) ( ENST00000556131.2, ENST00000557334.6, ENST00000256078.10, ENST00000311936.8, ENST00000685328.1, ENST00000686969.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 ) - Associated Disease
- Colorectal cancer metastatic
- Source Database
- DisGeNET
- Description
- Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis.
- Pubmed
- 22441566
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.08
- Year of publication
- 2012
Drugs